INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 1992

Dietary yeast intake was linked to higher disease activity in stable Crohn's disease.

Nineteen patients with stable Crohn's disease excluded dietary yeast for two months, receiving baker's yeast capsules during one month and placebo during the other. Mean Crohn's disease activity index was significantly higher when patients took baker's yeast (107.9) compared to yeast exclusion (102.1, p < 0.05). Maximum disease activity was also significantly lower during yeast exclusion (107.1) than during baseline (115.2) or yeast supplementation periods (113.9).

Study type
Clinical trial
Who was studied
19 patients with stable chronic Crohn's disease
What was measured
Crohn's disease activity index

THE PAPER

The effect of dietary yeast on the activity of stable chronic Crohn's disease.

Barclay GR, McKenzie H, Pennington J, Parratt D, Pennington CR. Scand J Gastroenterol, 1992.

PubMed 1502481 ↗DOI 10.3109/00365529208999948 ↗

Gut & microbiome

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.